IRCT20200623047902N5已完成未知
Bioequivalence study of Valsartan 160mg manufactured by Sanamed company in healthy volunteers
Sanamed pharma company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-60 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Valsartan
研究者
相似试验
尚未招募
不适用
Bioequivalence study of Valsartan 160 mg tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Karen Pharma and Food Supplement Co. Valsartan 160 mg tablet with brand Diovan® 160 mg tablet Novartis pharmaceuticals...IRCT20180620040164N18Karen Pharma and Food Supplement Co.24
招募中
Unknown
Investigating bioequivalence of valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N15Tabriz University of Medical Sciences24
招募中
不适用
Bioequivalence of Valsartan tabletsIRCT20170717035129N1Hakim Pharmaceutical Company26
已完成
不适用
Bioequivalence of ValsartaIRCT20210201050197N2Razak Pharmaceutical Company26
招募中
Unknown
Bioequivalence study of ?valsartan/sacobitril 200mg tabletIRCT20200105046010N86Tabriz University of Medical Sciences24